NCT06912815View on ClinicalTrials.gov

Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization.

NARecruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Crohn Disease (CD)
Interventions
BIOLOGICAL

ustekinumab and semi enteral nutrition

Preoperative treatment optimization involves a single intravenous induction with UST, followed by 6 weeks of oral/nasal feeding with semi-enteral nutrition.

OTHER

Exclusive enteral nutrition

Preoperative optimized treatment with 6 weeks of oral/nasal feeding of exclusive enteral nutrition alone.

Trial Locations (1)

510655

RECRUITING

Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Xiang Gao

OTHER